| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $570.4M | +20.0% |
| Cost of Revenue | $55.9M | +10.3% |
| Gross Profit | $514.5M | +21.1% |
| R&D Expense | $93.0M | +13.5% |
| SG&A Expense | $45.7M | +20.7% |
| Operating Income | $227.8M | +39.0% |
| Pre-tax Income | $263.6M | +42.3% |
| Income Tax | $40.4M | +7.4% |
| Net Income | $223.2M |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $209.6M | +116.6% |
| Accounts Receivable | $128.4M | +26.7% |
| Current Assets | $1.09B | +19.2% |
| Total Assets | $1.26B | +17.1% |
| Current Liabilities | $156.3M | +6.1% |
| Total Liabilities | $181.7M | +2.1% |
| Stockholders' Equity | $1.08B | +20.1% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $273.3M | +48.4% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$29.3M | -193.9% |
| Financing Cash Flow | -$131.1M | +52.6% |
| Free Cash Flow | $273.3M | +48.6% |
| +51.2% |
| EPS (Basic) | $1.19 | +52.6% |
| EPS (Diluted) | $1.11 | +54.2% |